Jiwon Oh

10.1k total citations · 1 hit paper
170 papers, 4.1k citations indexed

About

Jiwon Oh is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Jiwon Oh has authored 170 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Pathology and Forensic Medicine, 31 papers in Neurology and 26 papers in Rheumatology. Recurrent topics in Jiwon Oh's work include Multiple Sclerosis Research Studies (105 papers), Peripheral Neuropathies and Disorders (16 papers) and Polyomavirus and related diseases (14 papers). Jiwon Oh is often cited by papers focused on Multiple Sclerosis Research Studies (105 papers), Peripheral Neuropathies and Disorders (16 papers) and Polyomavirus and related diseases (14 papers). Jiwon Oh collaborates with scholars based in Canada, United States and United Kingdom. Jiwon Oh's co-authors include Xavier Montalbán, Peter A. Calabresi, Ángela Vidal‐Jordana, Daniel S. Reich, Shiv Saidha, Scott D. Newsome, Dzung L. Pham, Paul O’Connor, Peter C.M. van Zijl and Elliot M. Frohman and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jiwon Oh

155 papers receiving 4.0k citations

Hit Papers

Multiple sclerosis: clinical aspects 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiwon Oh Canada 32 2.5k 883 751 673 670 170 4.1k
Judith Bellmann–Strobl Germany 38 2.4k 1.0× 1.4k 1.6× 437 0.6× 623 0.9× 728 1.1× 139 4.0k
Jan Dörr Germany 36 1.8k 0.7× 631 0.7× 373 0.5× 1.0k 1.5× 432 0.6× 76 3.3k
Ahmed Toosy United Kingdom 33 1.9k 0.8× 974 1.1× 1.1k 1.5× 569 0.8× 470 0.7× 88 3.5k
Simona Bonavita Italy 40 2.0k 0.8× 1.0k 1.2× 946 1.3× 243 0.4× 348 0.5× 182 4.8k
Clyde Markowitz United States 25 1.6k 0.6× 531 0.6× 337 0.4× 918 1.4× 464 0.7× 59 2.7k
Sven Schippling Germany 39 3.0k 1.2× 1.4k 1.6× 606 0.8× 1.4k 2.1× 1.0k 1.5× 117 5.8k
Teresa C. Frohman United States 36 2.8k 1.1× 1.0k 1.1× 584 0.8× 2.4k 3.5× 881 1.3× 111 4.8k
Robert Bermel United States 30 1.9k 0.8× 617 0.7× 508 0.7× 200 0.3× 519 0.8× 84 2.7k
Alexander U. Brandt Germany 46 3.2k 1.3× 1.8k 2.0× 824 1.1× 1.9k 2.9× 1.1k 1.6× 190 5.8k
Nikos Evangelou United Kingdom 37 4.3k 1.7× 1.8k 2.0× 1.4k 1.9× 274 0.4× 1.1k 1.6× 127 5.7k

Countries citing papers authored by Jiwon Oh

Since Specialization
Citations

This map shows the geographic impact of Jiwon Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiwon Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiwon Oh more than expected).

Fields of papers citing papers by Jiwon Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiwon Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiwon Oh. The network helps show where Jiwon Oh may publish in the future.

Co-authorship network of co-authors of Jiwon Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Jiwon Oh. A scholar is included among the top collaborators of Jiwon Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiwon Oh. Jiwon Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oh, Jiwon, Robert J. Fox, Douglas L. Arnold, et al.. (2025). Tolebrutinib Phase 2b Long-Term Extension Study. PubMed. 1(3). 1 indexed citations
2.
Guenette, Melanie, et al.. (2024). Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy. Drug Design Development and Therapy. Volume 18. 3025–3042. 3 indexed citations
3.
Oh, Jiwon, Paul S. Giacomini, V. Wee Yong, et al.. (2024). From progression to progress: The future of multiple sclerosis. SHILAP Revista de lepidopterología. 16. 2699776925–2699776925. 3 indexed citations
4.
Dal‐Bianco, Assunta, Jiwon Oh, Pascal Sati, & Martina Absinta. (2024). Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance. Therapeutic Advances in Neurological Disorders. 17. 4233587772–4233587772. 12 indexed citations
5.
Bsteh, Gabriel, Nik Krajnc, Patrick Altmann, et al.. (2024). Treating to target in multiple sclerosis: Do we know how to measure whether we hit it?. European Journal of Neurology. 31(12). e16526–e16526. 2 indexed citations
6.
Oh, Jiwon, Jens Schjodt‐Eriksen, Johan van Beek, et al.. (2024). Use of smartphone-based remote assessments of multiple sclerosis in Floodlight Open, a global, prospective, open-access study. Scientific Reports. 14(1). 122–122. 12 indexed citations
7.
Azevedo, Christina, Peter A. Calabresi, Bruce Cree, et al.. (2024). Choroid plexus volume differentiates MS from its mimics. Multiple Sclerosis Journal. 30(8). 1072–1076. 4 indexed citations
8.
Scalfari, Antonio, Anthony Traboulsee, Jiwon Oh, et al.. (2024). Smouldering‐Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions. Annals of Neurology. 96(5). 826–845. 36 indexed citations
9.
Joshi, Manish, et al.. (2023). Neural network algorithms predict new diffusion MRI data for multi-compartmental analysis of brain microstructure in a clinical setting. Magnetic Resonance Imaging. 102. 9–19. 1 indexed citations
10.
Kim, David, Aditya Bharatha, Courtney Casserly, et al.. (2022). Quantitative spinal cord MRI and sexual dysfunction in multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(4). 3090495370–3090495370. 4 indexed citations
11.
Walt, Anneke van der, Mastura Monif, Suzanne Hodgkinson, et al.. (2022). Prediction of relapse activity when switching to cladribine for multiple sclerosis. Multiple Sclerosis Journal. 29(1). 119–129. 3 indexed citations
12.
Anderson, Annika, Brian C. Healy, Jiwon Oh, et al.. (2022). Peripartum disease activity in moderately and severely disabled women with multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(2). 3090468118–3090468118. 4 indexed citations
13.
Schneider, Raphaël, Koroboshka Brand‐Arzamendi, Jeffrey Glaister, et al.. (2022). Plasma Neurofilament light levels are increased in people with Radiologically Isolated Syndrome (P1-1.Virtual). Neurology. 98(18_supplement). 1 indexed citations
14.
Oh, Jiwon, Suradech Suthiphosuwan, Pascal Sati, et al.. (2021). Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RIS. Multiple Sclerosis Journal. 27(14). 2199–2208. 39 indexed citations
15.
Bain, Julie, et al.. (2020). Early Real-World Safety, Tolerability, and Efficacy of Cladribine Tablets: A Single Center Experience (400). Neurology. 94(15_supplement). 2 indexed citations
16.
Suthiphosuwan, Suradech, Pascal Sati, Melanie Guenette, et al.. (2019). The Central Vein Sign in Radiologically Isolated Syndrome. American Journal of Neuroradiology. 40(5). 776–783. 42 indexed citations
17.
Zipp, Frauke, Jiwon Oh, Yára Dadalti Fragoso, & Emmanuelle Waubant. (2019). Implementing the 2017 McDonald criteria for the diagnosis of multiple sclerosis. Nature Reviews Neurology. 15(8). 441–445. 18 indexed citations
18.
Dworkin, Jordan D., Kristin A. Linn, İpek Oğuz, et al.. (2018). An Automated Statistical Technique for Counting Distinct Multiple Sclerosis Lesions. American Journal of Neuroradiology. 39(4). 626–633. 27 indexed citations
19.
Miller, Aaron, Mark Freedman, Jiwon Oh, et al.. (2017). Outcomes of the TOPIC Extension Study of Teriflunomide in Patients With Early Multiple Sclerosis: Up to 7 Years of Clinical Results (P2.103). Neurology. 88(16_supplement). 2 indexed citations
20.
Harrison, Daniel M., Snehashis Roy, Jiwon Oh, et al.. (2015). Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis. JAMA Neurology. 72(9). 1004–1004. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026